World Health Organization. The group of experts, in the BMJ medical journal on Thursday, said that the drugs, fluvoxamine and colchicine, could potentially cause harm.
Citing lack of data, the panel didn’t give advice for severe infection. The WHO said that the two medicines are commonly used, inexpensive drugs that have received considerable interest as potential COVID treatments during the pandemic.
Fluvoxamine is used for depression and obsessive-compulsive disorders and has been prescribed for almost 30 years. in a study published in the Lancet Global Health journal last October, The medicine was found to slightly reduce the risk of hospitalization in COVID.
Data from three randomized controlled trials involving over 2,000 patients for fluvoxamine and seven such tests with 16,484 patients for colchicine, said the experts.